1. Home
  2. FA vs VCYT Comparison

FA vs VCYT Comparison

Compare FA & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Advantage Corporation

FA

First Advantage Corporation

HOLD

Current Price

$15.84

Market Cap

2.6B

ML Signal

HOLD

Logo Veracyte Inc.

VCYT

Veracyte Inc.

HOLD

Current Price

$49.67

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FA
VCYT
Founded
2003
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.1B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
FA
VCYT
Price
$15.84
$49.67
Analyst Decision
Buy
Strong Buy
Analyst Count
4
7
Target Price
$15.67
$44.00
AVG Volume (30 Days)
1.0M
1.1M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
72.97
164.52
EPS
0.01
0.35
Revenue
$1,574,389,000.00
N/A
Revenue This Year
$8.42
$13.76
Revenue Next Year
$7.26
$12.35
P/E Ratio
$1,577.00
$142.69
Revenue Growth
83.02
N/A
52 Week Low
$8.82
$22.61
52 Week High
$19.01
$50.71

Technical Indicators

Market Signals
Indicator
FA
VCYT
Relative Strength Index (RSI) 59.09 75.40
Support Level $15.63 $40.27
Resistance Level $16.19 $50.71
Average True Range (ATR) 0.69 2.34
MACD -0.03 0.42
Stochastic Oscillator 52.72 95.40

Price Performance

Historical Comparison
FA
VCYT

About FA First Advantage Corporation

First Advantage Corp is a provider of software and data in the Human Resources technology industry. The company provides end-to-end identity solutions, criminal background screening, credential verifications, drug and health screening, and continuous risk monitoring. It combines AI-powered proprietary technology platforms with proprietary data, primary source data, and third-party data. Its reportable segments are First Advantage Americas, First Advantage International, and Sterling. The company generates maximum revenue from the Sterling segment, which provides similar services as compared to First Advantage's Americas and International segments on a global basis. Geographically, the company generates the majority of its revenue from the United States.

About VCYT Veracyte Inc.

Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).

Share on Social Networks: